140 related articles for article (PubMed ID: 19106606)
1. Dimerization of the core domain of the p53 family: a computational study.
Madhumalar A; Jun LH; Lane DP; Verma CS
Cell Cycle; 2009 Jan; 8(1):137-48. PubMed ID: 19106606
[TBL] [Abstract][Full Text] [Related]
2. Conformational stability and activity of p73 require a second helix in the tetramerization domain.
Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V
Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140
[TBL] [Abstract][Full Text] [Related]
3. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
[TBL] [Abstract][Full Text] [Related]
4. Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain.
Heering J; Jonker HR; Löhr F; Schwalbe H; Dötsch V
Protein Sci; 2016 Feb; 25(2):410-22. PubMed ID: 26473758
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
van Dieck J; Brandt T; Teufel DP; Veprintsev DB; Joerger AC; Fersht AR
Oncogene; 2010 Apr; 29(14):2024-35. PubMed ID: 20140014
[TBL] [Abstract][Full Text] [Related]
6. High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53.
Klein C; Georges G; Künkele KP; Huber R; Engh RA; Hansen S
J Biol Chem; 2001 Oct; 276(40):37390-401. PubMed ID: 11477076
[TBL] [Abstract][Full Text] [Related]
7. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
Ethayathulla AS; Nguyen HT; Viadiu H
J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
[TBL] [Abstract][Full Text] [Related]
9. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
[TBL] [Abstract][Full Text] [Related]
10. Differences in the transactivation domains of p53 family members: a computational study.
Mavinahalli JN; Madhumalar A; Beuerman RW; Lane DP; Verma C
BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S5. PubMed ID: 20158876
[TBL] [Abstract][Full Text] [Related]
11. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for ASPP2 recognition by the tumor suppressor p73.
Canning P; von Delft F; Bullock AN
J Mol Biol; 2012 Nov; 423(4):515-27. PubMed ID: 22917970
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
14. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Ciribilli Y; Monti P; Bisio A; Nguyen HT; Ethayathulla AS; Ramos A; Foggetti G; Menichini P; Menendez D; Resnick MA; Viadiu H; Fronza G; Inga A
Nucleic Acids Res; 2013 Oct; 41(18):8637-53. PubMed ID: 23892287
[TBL] [Abstract][Full Text] [Related]
15. Impact of cadmium, cobalt and nickel on sequence-specific DNA binding of p63 and p73 in vitro and in cells.
Adámik M; Bažantová P; Navrátilová L; Polášková A; Pečinka P; Holaňová L; Tichý V; Brázdová M
Biochem Biophys Res Commun; 2015 Jan; 456(1):29-34. PubMed ID: 25446071
[TBL] [Abstract][Full Text] [Related]
16. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
[TBL] [Abstract][Full Text] [Related]
17. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.
Sauer M; Bretz AC; Beinoraviciute-Kellner R; Beitzinger M; Burek C; Rosenwald A; Harms GS; Stiewe T
Nucleic Acids Res; 2008 Apr; 36(6):1900-12. PubMed ID: 18267967
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.
Kehrloesser S; Osterburg C; Tuppi M; Schäfer B; Vousden KH; Dötsch V
Cell Death Differ; 2016 Dec; 23(12):1952-1960. PubMed ID: 27447112
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
Robinson RA; Lu X; Jones EY; Siebold C
Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
[TBL] [Abstract][Full Text] [Related]
20. p53 family members: similar biochemistry, different biology.
Barbieri CE; Pietenpol JA
Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
